PERSPECTA

News from every angle

← Back to headlines

Baron Capital Exits Apogee Therapeutics Following AbbVie Buyout

Baron Capital has divested its holdings in Apogee Therapeutics (APGE) after the company was acquired by AbbVie.

5 Aug, 12:17 — 5 Aug, 12:17
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual22d ago

Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout

Read full article →

Related Stories

Companies Report Strong Earnings Highlighted by AI-Driven Growth

52m ago

Samsung Biologics Launches $2.2 Billion Rights Offering for PolyPeptide Deal

55m ago

Markets Brace for Fed Chair Warsh’s Jackson Hole Keynote on Rates

1h ago

Venezuela Considers Leaving OPEC Amid Warming US Ties

1h ago